Outcomes and Practice Patterns of Long-Acting Injectable Versus Oral Antipsychotics Among Patients With Bipolar I Disorder in the United States
<b>Conclusions:</b> LAIs, especially SG formulations, are associated with reduced rehospitalization in BD-I compared to OAs, supporting their broader use to improve adherence and reduce readmissions.
Authors
- Julian Casciano
- Arti Phatak (ORCID: https://orcid.org/0000-0003-3856-1754)
- Zenobia Dotiwala
- Mark Suett (ORCID: https://orcid.org/0000-0002-6840-1535)
- Lynda J. Krasenbaum
- Sigal Kaplan (ORCID: https://orcid.org/0000-0002-3352-8480)
- Martha Sajatovic
- Ying Zhang
Institutions
- University Hospitals of Cleveland (US)
- Harlow College (GB)
- Delray Medical Center (US)
- Teva Pharmaceuticals (Israel) (IL)
- Reckitt Benckiser (United States) (US)
- Renewable Spirits (United States) (US)
- Teva Pharmaceuticals (United States) (US)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- The Journal of Clinical Psychiatry
- Published
- 2026-03-02
- DOI
- https://doi.org/10.4088/jcp.25m16154
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00